Join us now & support harm reduction!

    We respect your privacy. Unsubscribe at anytime.
    Latest
    News

    Europe’s cancer league wants a tobacco free Europe, but doesn’t talk about tobacco at all. Why?

    Alastair Cohen
    Alastair Cohen
    July 2, 2024
    4 min read
    Download Source FilesDownload Source Files

    That headline isn’t a rhetorical question: it was what we were genuinely thinking after we watched a YouTube replay of a conference call organised by the European Cancer League.

    “How will Europe achieve it’s first tobacco free generation?”, questions the title of the webinar. Fair enough, we thought, so presumably they’ll talk about how to reduce the prevalence of smoking. After all, cigarettes are over 90% of the European nicotine market, and they kill half of their users. Right?

    Wrong.

    There was only a single mention of smoking during the whole hour and 40 minute conference call; and that almost served to underline just how far from the mission of reducing smoking related disease many in public health have come.

    But why aren’t we talking about smoking?

    Towards the end of the webinar, one attendee who asked an anonymous question received quite the response from moderator Mariam Zaidi, which we thought was quite telling. You can watch it in full below - we’ve started the clip where all this happened:

    The question apparently asked was why the panel was only talking about e-cigarettes when traditional products still make up 95% of the market. Seems like a sensible observation. But Zaidi seemed shocked.

    “I thought ‘there’s no way someone’s going to ask that question’”, Zaidi says by way of introduction, going on to scold the participant who had the temerity to ask it: “you really shouldn’t be asking this”.

    Zaidi then goes on to suggest that the question was along the lines of “why should we even care about novel and emerging products?”. 

    Zaidi’s reaction to what should be a fairly basic question: why aren’t we talking about the products which dominate the market and kill people in a seminar on tobacco policy, speaks volumes about the contempt with which many in the public health establishment view those who offer even the slightest disagreement with their dogma.

    But that’s not all…

    The oddness of the whole event started right from the beginning, when Lilia Olefir - who runs Europe’s tobacco control lobby “Smoke Free Partnership” showed the audience a picture of a French product called “sniffy”, which apparently can be bought in tobacco stores in France and which you seem to use like cocaine. Seems scary, huh?

    But that’s exactly the point. We’d never heard of this product, and Google wasn’t helping, but luckily one participant, Dr Jerome Foucard, was on hand to explain.

    “There is no nicotine in this product”, he told the audience in a matter-of-fact kind of way. OK - so why was it relevant to the Smoke-Free Partnership or to the webinar at all? 

    We can only assume that it was used to scare participants and regulators alike, never mind that it’s completely irrelevant to the debate: “it looks like hard drug use, so we’ll see if we can connect it somehow”, they must have thought.

    Credit to Foucard - he mentioned a few times that vaping is clearly far less harmful than smoking, much to the annoyance of the representative of the WHO on the panel

    Evidence free statements abound

    We were also somewhat taken aback by the ignorance of some of the panellists about the products that they all hate so much.

    “Data and evidence shows that those smokers that are 40-50 years old…they use tobacco flavour, they don’t use cloud flavour or candy flavour” asserted Carlos Torrado Ortega, from the European Cancer League. What data and evidence, we asked ourselves?

    We’re happy to be corrected on this point, but we couldn’t find a single study that supports the statement that older smokers who use vaping to quit only use tobacco flavour, but we can find plenty of evidence to the contrary.

    A lot of the analysis we’ve found is inconclusive, but those who have reached firm conclusions note the importance of non tobacco flavours for adult smokers who want to quit. One study from New Zealand concludes:

    Flavours play a major role in vaping initiation for current smokers, former smokers and vaping-susceptible non-smokers, and remain important to those who continue vaping. Our findings highlight the need for regulation that allows some flavour diversity

    Another, from the UK, hails the importance of advice on flavours specifically to aid quitting:

    “The simplicity of tailored support through flavour advice and supportive messages could have a huge impact in helping people lead smoke-free lives”, the study’s author concludes.

    True, these are two studies among many, and others question the role of flavours when it comes to cessation. But not one single study that we could find suggests that older smokers only want tobacco flavours. So why say it?

    Ortega also showed more gaps in his knowledge when it came to nicotine pouches:

    “You see all these colourful candies and you put them in your mouth, but what you don’t know is that they can have up to 40mg of nicotine in them”, he asserts casually.

    Let us tell you, if you’re using a nicotine pouch with 40mg of nicotine, the unpleasant stinging sensation will let you know about it fairly quickly.

    Ortega then goes on to tell the audience that “when you want more nicotine pouches, you will want more electronic cigarettes, and then you will also want to try normal cigarettes”.

    Again, where is the evidence for any of this? We don’t know of any; what we do know is that an analog product - snus - has been on the Swedish market for decades, and cigarette use there has fallen to almost 5%: if Ortega were right, you’d expect Sweden to have higher smoking rates than anywhere else.

    Fighting dirty

    We could go on, but this gives you a pretty good flavour of what happened. The whole webinar is available on the European Cancer League’s YouTube channel for those of you who are masochistic enough to want to watch the whole thing. 

    But the point is this: the organisations who presented in this webinar - the WHO, the Smoke Free Partnership, the European Cancer League and so on - are desperate to get the EU to regulate safer nicotine products out of existence, their lobbying power is great, and they do not tolerate dissent. The next few years, when the European Union will decide whether and how to increase regulation on safer nicotine products, will be characterised by this kind of campaigning; consumers need to be ready to fight their corner too.

    Take Action Now!

    Sign up to our newsletter to get important news and alerts as it happens

    By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

    FAQs

    Faire campagne peut être difficile, surtout si ce n'est pas votre travail à plein temps, mais nous sommes ici pour vous simplifier la tâche. Dans cette section, vous trouverez des réponses aux questions fréquemment posées sur les processus législatifs, les stratégies de plaidoyer et comment vous pouvez participer efficacement à l'élaboration des politiques.

    Qu'est-ce que le plaidoyer et comment puis-je m'impliquer ?

    En termes simples, le plaidoyer consiste à organiser un groupe de personnes partageant les mêmes idées pour faire campagne en faveur d'un changement de politique gouvernementale en parlant aux personnes au pouvoir. Cela peut prendre diverses formes : publier sur les réseaux sociaux, écrire à vos politiciens locaux, organiser des réunions avec le gouvernement ou répondre aux consultations. Nous vous aidons en fournissant les informations et les outils nécessaires pour le faire efficacement.

    Comment puis-je suivre l'avancement de la législation ?

    Les sites web gouvernementaux contiennent généralement une liste des dossiers législatifs en cours de devenir loi. Cependant, ces sites sont conçus pour les professionnels du droit et de la politique, et peuvent souvent être déroutants pour le grand public. Nous vous aidons en restant à l'écoute des développements dans les propositions de réduction des méfaits du tabac, puis nous vous fournissons un résumé facile à utiliser.

    Quelle est la meilleure façon de contacter mes représentants ?

    Les politiciens sont aussi des gens, et comme tout le monde, la meilleure façon de leur transmettre des messages varie d'une personne à l'autre. Certains préfèrent les e-mails ou même le courrier traditionnel, tandis que d'autres consultent constamment leurs flux de médias sociaux. Ils ont cependant un point commun : ils doivent rester informés des préoccupations des personnes qu'ils représentent.Nous vous aidons à trouver vos représentants en tenant des bases de données de politiciens et de candidats à travers l'Europe, avec tous leurs coordonnées, pour que vous puissiez rapidement savoir comment joindre la personne qu'il vous faut.

    Puis-je faire une différence ?

    Oui ! La seule raison pour laquelle la réduction des méfaits est encore vivante en Europe aujourd'hui est que des personnes comme vous, sans expérience politique ou de campagne, ont agi pour protéger la disponibilité des produits sur lesquels elles comptent pour rester sans fumée. Nous avons de nombreux articles qui parlent des moments et des manières dont cela s'est produit dans le passé, que nous espérons vous inspireront à vous impliquer et à faire une différence.

    Encore des questions ?

    Envoyez-nous un e-mail et nous vous répondrons.

    Stay Updated with Our Newsletter

    Sign up for our newsletter to receive regular updates and stay engaged.

    By joining, you agree to our Terms and Conditions.
    Faites partie de quelque chose de grand

    Rejoignez la communauté

    Apportez un changement positif dans le domaine de la réduction des méfaits du tabac.
    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.
    E-mail
    Envoyez-nous un e-mail à l'adresse suivante :
    hello@clearingtheair.eu